Cargando…
Novel Treatments in Lupus
Purpose of Review: The standard treatment options for systemic lupus erythematosus (SLE) are focused on non-specific immunosuppression. Over the past few years, scientific studies and ongoing clinical trials have shifted the paradigm with rapid advances in developing biologics and small molecules. A...
Autores principales: | Vukelic, Milena, Li, Yi, Kyttaris, Vasileios C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262343/ https://www.ncbi.nlm.nih.gov/pubmed/30524430 http://dx.doi.org/10.3389/fimmu.2018.02658 |
Ejemplares similares
-
Treatment with Anti-Interleukin 23 Antibody Ameliorates Disease in Lupus-Prone Mice
por: Kyttaris, Vasileios C., et al.
Publicado: (2013) -
Polyarticular septic arthritis caused by Staphylococcus lugdunensis in a patient with systemic lupus erythematosus
por: Laloo, Anita, et al.
Publicado: (2018) -
Targeting Syk in Autoimmune Rheumatic Diseases
por: Deng, Guo-Min, et al.
Publicado: (2016) -
T cell Metabolism in Lupus
por: Vukelic, Milena, et al.
Publicado: (2020) -
Journal Club: Efficacy and Safety of Voclosporin Versus Placebo for Lupus Nephritis (AURORA 1): A Double‐Blind, Randomized, Multicenter, Placebo‐Controlled, Phase 3 Trial
por: Rubio, Jose, et al.
Publicado: (2021)